Evidence map›Paper›PMID 34071094›Full record

ReviewInternational journal of molecular sciences2021

The Crossroads between Host Copper Metabolism and Influenza Infection.

Ludmila V Puchkova, Irina V Kiseleva, Elena V Polishchuk, Massimo Broggini, Ekaterina Yu Ilyechova

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Ludmila V PuchkovaInternational Research Laboratory of Trace Elements Metabolism, ADTS Institute, RC AFMLCS, ITMO University, 197101 St. Petersburg, Russia.ORCID 0000-0003-0958-2812
Irina V KiselevaDepartment of Virology, Institute of Experimental Medicine, 197376 St. Petersburg, Russia.ORCID 0000-0002-3892-9873
Elena V PolishchukTelethon Institute of Genetics and Medicine, Pozzuoli, 80078 Naples, Italy.
Massimo BrogginiIstituto di Ricerche Farmacologiche "Mario Negri", IRCCS, 20156 Milan, Italy.ORCID 0000-0002-8138-9358
Ekaterina Yu IlyechovaInternational Research Laboratory of Trace Elements Metabolism, ADTS Institute, RC AFMLCS, ITMO University, 197101 St. Petersburg, Russia.ORCID 0000-0002-5623-2156
ITMO University · RUInstitute of Experimental Medicine · RUMario Negri Institute for Pharmacological Research · ITTelethon Institute Of Genetics And Medicine · IT

Funding

Russian Foundation for Basic Research 18-515-7811Russian Foundation for Basic Research 20-515-7813
6 · The paper itself

Abstract

Three main approaches are used to combat severe viral respiratory infections. The first is preemptive vaccination that blocks infection. Weakened or dead viral particles, as well as genetic constructs carrying viral proteins or information about them, are used as an antigen. However, the viral genome is very evolutionary labile and changes continuously. Second, chemical agents are used during infection and inhibit the function of a number of viral proteins. However, these drugs lose their effectiveness because the virus can rapidly acquire resistance to them. The third is the search for points in the host metabolism the effect on which would suppress the replication of the virus but would not have a significant effect on the metabolism of the host. Here, we consider the possibility of using the copper metabolic system as a target to reduce the severity of influenza infection. This is facilitated by the fact that, in mammals, copper status can be rapidly reduced by silver nanoparticles and restored after their cancellation.

Indexed as

AnimalsAntiviral AgentsCeruloplasminCopperCopper-Transporting ATPasesCopper Transport ProteinsDrug Resistance, ViralHost-Pathogen InteractionsHumansInfluenza A virusInfluenza, HumanInfluenza VaccinesMammalsMetal NanoparticlesMolecular ChaperonesPrPC ProteinsAntiviral AgentsATP7A protein, humanCCS protein, humanCeruloplasminCopperCopper-Transporting ATPasesCopper Transport ProteinsInfluenza VaccinesMolecular ChaperonesPrPC ProteinsRNA, ViralSilverSOD1 protein, humanSuperoxide Dismutase-1Viral Proteinsceruloplasmincopper metabolisminfluenza virus replicative cyclesilver nanoparticles

Identifiers

PMID34071094
PMCPMC8197124
OpenAlexW3163987594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.